img

Global and United States Broad Spectrum Antibiotics Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and United States Broad Spectrum Antibiotics Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and United States Broad Spectrum Antibiotics Market
This report focuses on global and United States Broad Spectrum Antibiotics market, also covers the segmentation data of other regions in regional level and county level.
The global Broad Spectrum Antibiotics revenue was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period (2024-2034).
In United States the Broad Spectrum Antibiotics revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period (2024-2034).
The global key players of Broad Spectrum Antibiotics include Merck, AbbVie, GSK, Pfizer Inc., Melinta Therapeutics, Basilea Pharmaceutica, Abbott, Sanofi and Novartis AG, etc. The global five biggest players hold a share of % in 2024.
Global Broad Spectrum Antibiotics Scope and Market Size
Broad Spectrum Antibiotics market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Broad Spectrum Antibiotics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2034.
For United States market, this report focuses on the Broad Spectrum Antibiotics market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.



By Company


Merck
AbbVie
GSK
Pfizer Inc.
Melinta Therapeutics
Basilea Pharmaceutica
Abbott
Sanofi
Novartis AG
Bayer AG
Bristol Myers Squibb
Tetraphase Pharmaceuticals
Paratek Pharmaceuticals
Nabriva Therapeutics
Spero Therapeutics
Janssen Pharmaceuticals
Segment by Type
Polypeptide
Aminoglycosides
Tetracycline
Macrolides
Others

Segment by Application


Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Broad Spectrum Antibiotics definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Broad Spectrum Antibiotics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Broad Spectrum Antibiotics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Broad Spectrum Antibiotics sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Broad Spectrum Antibiotics Product Introduction
1.2 Global Broad Spectrum Antibiotics Outlook 2018 VS 2024 VS 2034
1.2.1 Global Broad Spectrum Antibiotics Sales in US$ Million for the Year 2018-2034
1.2.2 Global Broad Spectrum Antibiotics Sales in Volume for the Year 2018-2034
1.3 United States Broad Spectrum Antibiotics Outlook 2018 VS 2024 VS 2034
1.3.1 United States Broad Spectrum Antibiotics Sales in US$ Million for the Year 2018-2034
1.3.2 United States Broad Spectrum Antibiotics Sales in Volume for the Year 2018-2034
1.4 Broad Spectrum Antibiotics Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of United States Broad Spectrum Antibiotics in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Broad Spectrum Antibiotics Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.5 Broad Spectrum Antibiotics Market Dynamics
1.5.1 Broad Spectrum Antibiotics Industry Trends
1.5.2 Broad Spectrum Antibiotics Market Drivers
1.5.3 Broad Spectrum Antibiotics Market Challenges
1.5.4 Broad Spectrum Antibiotics Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Broad Spectrum Antibiotics by Type
2.1 Broad Spectrum Antibiotics Market Segment by Type
2.1.1 Polypeptide
2.1.2 Aminoglycosides
2.1.3 Tetracycline
2.1.4 Macrolides
2.1.5 Others
2.2 Global Broad Spectrum Antibiotics Market Size by Type
2.2.1 Global Broad Spectrum Antibiotics Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global Broad Spectrum Antibiotics Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global Broad Spectrum Antibiotics Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 United States Broad Spectrum Antibiotics Market Size by Type
2.3.1 United States Broad Spectrum Antibiotics Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 United States Broad Spectrum Antibiotics Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 United States Broad Spectrum Antibiotics Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 Broad Spectrum Antibiotics by Application
3.1 Broad Spectrum Antibiotics Market Segment by Application
3.1.1 Hospital Pharmacy
3.1.2 Retail Pharmacy
3.1.3 Online Pharmacy
3.2 Global Broad Spectrum Antibiotics Market Size by Application
3.2.1 Global Broad Spectrum Antibiotics Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global Broad Spectrum Antibiotics Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global Broad Spectrum Antibiotics Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 United States Broad Spectrum Antibiotics Market Size by Application
3.3.1 United States Broad Spectrum Antibiotics Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 United States Broad Spectrum Antibiotics Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 United States Broad Spectrum Antibiotics Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global Broad Spectrum Antibiotics Competitor Landscape by Company
4.1 Global Broad Spectrum Antibiotics Market Size by Company
4.1.1 Global Key Manufacturers of Broad Spectrum Antibiotics, Ranked by Revenue (2024)
4.1.2 Global Broad Spectrum Antibiotics Revenue by Manufacturer (2018-2023)
4.1.3 Global Broad Spectrum Antibiotics Sales by Manufacturer (2018-2023)
4.1.4 Global Broad Spectrum Antibiotics Price by Manufacturer (2018-2023)
4.2 Global Broad Spectrum Antibiotics Concentration Ratio (CR)
4.2.1 Broad Spectrum Antibiotics Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Broad Spectrum Antibiotics in 2024
4.2.3 Global Broad Spectrum Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Broad Spectrum Antibiotics, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Broad Spectrum Antibiotics, Product Offered and Application
4.5 Global Key Manufacturers of Broad Spectrum Antibiotics, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Broad Spectrum Antibiotics Market Size by Company
4.7.1 Key Players of Broad Spectrum Antibiotics in United States, Ranked by Revenue (2024)
4.7.2 United States Broad Spectrum Antibiotics Revenue by Players (2018-2023)
4.7.3 United States Broad Spectrum Antibiotics Sales by Players (2018-2023)
5 Global Broad Spectrum Antibiotics Market Size by Region
5.1 Global Broad Spectrum Antibiotics Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Broad Spectrum Antibiotics Market Size in Volume by Region (2018-2034)
5.2.1 Global Broad Spectrum Antibiotics Sales in Volume by Region: 2018-2023
5.2.2 Global Broad Spectrum Antibiotics Sales in Volume Forecast by Region (2024-2034)
5.3 Global Broad Spectrum Antibiotics Market Size in Value by Region (2018-2034)
5.3.1 Global Broad Spectrum Antibiotics Sales in Value by Region: 2018-2023
5.3.2 Global Broad Spectrum Antibiotics Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Broad Spectrum Antibiotics Market Size YoY Growth 2018-2034
6.2 Americas Broad Spectrum Antibiotics Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas Broad Spectrum Antibiotics Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas Broad Spectrum Antibiotics Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Broad Spectrum Antibiotics Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Broad Spectrum Antibiotics Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Broad Spectrum Antibiotics Market Size YoY Growth 2018-2034
7.2 EMEA Broad Spectrum Antibiotics Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA Broad Spectrum Antibiotics Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA Broad Spectrum Antibiotics Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Broad Spectrum Antibiotics Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Broad Spectrum Antibiotics Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Broad Spectrum Antibiotics Market Size YoY Growth 2018-2034
8.2 China Broad Spectrum Antibiotics Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China Broad Spectrum Antibiotics Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC Broad Spectrum Antibiotics Market Size YoY Growth 2018-2034
9.2 APAC Broad Spectrum Antibiotics Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC Broad Spectrum Antibiotics Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC Broad Spectrum Antibiotics Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Broad Spectrum Antibiotics Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Broad Spectrum Antibiotics Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Description and Business Overview
10.1.3 Merck Broad Spectrum Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck Broad Spectrum Antibiotics Products Offered
10.1.5 Merck Recent Development
10.2 AbbVie
10.2.1 AbbVie Company Information
10.2.2 AbbVie Description and Business Overview
10.2.3 AbbVie Broad Spectrum Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.2.4 AbbVie Broad Spectrum Antibiotics Products Offered
10.2.5 AbbVie Recent Development
10.3 GSK
10.3.1 GSK Company Information
10.3.2 GSK Description and Business Overview
10.3.3 GSK Broad Spectrum Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.3.4 GSK Broad Spectrum Antibiotics Products Offered
10.3.5 GSK Recent Development
10.4 Pfizer Inc.
10.4.1 Pfizer Inc. Company Information
10.4.2 Pfizer Inc. Description and Business Overview
10.4.3 Pfizer Inc. Broad Spectrum Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Pfizer Inc. Broad Spectrum Antibiotics Products Offered
10.4.5 Pfizer Inc. Recent Development
10.5 Melinta Therapeutics
10.5.1 Melinta Therapeutics Company Information
10.5.2 Melinta Therapeutics Description and Business Overview
10.5.3 Melinta Therapeutics Broad Spectrum Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Melinta Therapeutics Broad Spectrum Antibiotics Products Offered
10.5.5 Melinta Therapeutics Recent Development
10.6 Basilea Pharmaceutica
10.6.1 Basilea Pharmaceutica Company Information
10.6.2 Basilea Pharmaceutica Description and Business Overview
10.6.3 Basilea Pharmaceutica Broad Spectrum Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Basilea Pharmaceutica Broad Spectrum Antibiotics Products Offered
10.6.5 Basilea Pharmaceutica Recent Development
10.7 Abbott
10.7.1 Abbott Company Information
10.7.2 Abbott Description and Business Overview
10.7.3 Abbott Broad Spectrum Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Abbott Broad Spectrum Antibiotics Products Offered
10.7.5 Abbott Recent Development
10.8 Sanofi
10.8.1 Sanofi Company Information
10.8.2 Sanofi Description and Business Overview
10.8.3 Sanofi Broad Spectrum Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Sanofi Broad Spectrum Antibiotics Products Offered
10.8.5 Sanofi Recent Development
10.9 Novartis AG
10.9.1 Novartis AG Company Information
10.9.2 Novartis AG Description and Business Overview
10.9.3 Novartis AG Broad Spectrum Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Novartis AG Broad Spectrum Antibiotics Products Offered
10.9.5 Novartis AG Recent Development
10.10 Bayer AG
10.10.1 Bayer AG Company Information
10.10.2 Bayer AG Description and Business Overview
10.10.3 Bayer AG Broad Spectrum Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Bayer AG Broad Spectrum Antibiotics Products Offered
10.10.5 Bayer AG Recent Development
10.11 Bristol Myers Squibb
10.11.1 Bristol Myers Squibb Company Information
10.11.2 Bristol Myers Squibb Description and Business Overview
10.11.3 Bristol Myers Squibb Broad Spectrum Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Bristol Myers Squibb Broad Spectrum Antibiotics Products Offered
10.11.5 Bristol Myers Squibb Recent Development
10.12 Tetraphase Pharmaceuticals
10.12.1 Tetraphase Pharmaceuticals Company Information
10.12.2 Tetraphase Pharmaceuticals Description and Business Overview
10.12.3 Tetraphase Pharmaceuticals Broad Spectrum Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Tetraphase Pharmaceuticals Broad Spectrum Antibiotics Products Offered
10.12.5 Tetraphase Pharmaceuticals Recent Development
10.13 Paratek Pharmaceuticals
10.13.1 Paratek Pharmaceuticals Company Information
10.13.2 Paratek Pharmaceuticals Description and Business Overview
10.13.3 Paratek Pharmaceuticals Broad Spectrum Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Paratek Pharmaceuticals Broad Spectrum Antibiotics Products Offered
10.13.5 Paratek Pharmaceuticals Recent Development
10.14 Nabriva Therapeutics
10.14.1 Nabriva Therapeutics Company Information
10.14.2 Nabriva Therapeutics Description and Business Overview
10.14.3 Nabriva Therapeutics Broad Spectrum Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Nabriva Therapeutics Broad Spectrum Antibiotics Products Offered
10.14.5 Nabriva Therapeutics Recent Development
10.15 Spero Therapeutics
10.15.1 Spero Therapeutics Company Information
10.15.2 Spero Therapeutics Description and Business Overview
10.15.3 Spero Therapeutics Broad Spectrum Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Spero Therapeutics Broad Spectrum Antibiotics Products Offered
10.15.5 Spero Therapeutics Recent Development
10.16 Janssen Pharmaceuticals
10.16.1 Janssen Pharmaceuticals Company Information
10.16.2 Janssen Pharmaceuticals Description and Business Overview
10.16.3 Janssen Pharmaceuticals Broad Spectrum Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Janssen Pharmaceuticals Broad Spectrum Antibiotics Products Offered
10.16.5 Janssen Pharmaceuticals Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Broad Spectrum Antibiotics Industry Chain Analysis
11.2 Broad Spectrum Antibiotics Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Broad Spectrum Antibiotics Production Mode & Process
11.4 Broad Spectrum Antibiotics Sales and Marketing
11.4.1 Broad Spectrum Antibiotics Sales Channels
11.4.2 Broad Spectrum Antibiotics Distributors
11.5 Broad Spectrum Antibiotics Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Broad Spectrum Antibiotics CAGR in Value, United States VS Global, 2018 VS 2024 VS 2034
Table 2. Broad Spectrum Antibiotics Market Trends
Table 3. Broad Spectrum Antibiotics Market Drivers
Table 4. Broad Spectrum Antibiotics Market Challenges
Table 5. Broad Spectrum Antibiotics Market Restraints
Table 6. Global Broad Spectrum Antibiotics Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. United States Broad Spectrum Antibiotics Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Broad Spectrum Antibiotics Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. United States Broad Spectrum Antibiotics Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Broad Spectrum Antibiotics, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Broad Spectrum Antibiotics Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Broad Spectrum Antibiotics Revenue Share by Manufacturer, 2018-2023
Table 13. Global Broad Spectrum Antibiotics Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Broad Spectrum Antibiotics Sales Share by Manufacturer, 2018-2023
Table 15. Global Broad Spectrum Antibiotics Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Broad Spectrum Antibiotics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Broad Spectrum Antibiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Broad Spectrum Antibiotics as of 2024)
Table 18. Global Key Manufacturers of Broad Spectrum Antibiotics, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Broad Spectrum Antibiotics, Product Offered and Application
Table 20. Global Key Manufacturers of Broad Spectrum Antibiotics, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Broad Spectrum Antibiotics in United States, Ranked by Revenue (2024) & (US$ million)
Table 23. United States Broad Spectrum Antibiotics Revenue by Players, (US$ Million), (2018-2023)
Table 24. United States Broad Spectrum Antibiotics Revenue Share by Players, (2018-2023)
Table 25. United States Broad Spectrum Antibiotics Sales by Players, (K Units), (2018-2023)
Table 26. United States Broad Spectrum Antibiotics Sales Share by Players, (2018-2023)
Table 27. Global Broad Spectrum Antibiotics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Broad Spectrum Antibiotics Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Broad Spectrum Antibiotics Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global Broad Spectrum Antibiotics Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Broad Spectrum Antibiotics Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Broad Spectrum Antibiotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Broad Spectrum Antibiotics Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Broad Spectrum Antibiotics Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Broad Spectrum Antibiotics Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Broad Spectrum Antibiotics Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA Broad Spectrum Antibiotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Broad Spectrum Antibiotics Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Broad Spectrum Antibiotics Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Broad Spectrum Antibiotics Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Broad Spectrum Antibiotics Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC Broad Spectrum Antibiotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Broad Spectrum Antibiotics Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Broad Spectrum Antibiotics Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Broad Spectrum Antibiotics Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Broad Spectrum Antibiotics Sales in Volume by Country (2024-2034) & (K Units)
Table 47. Merck Company Information
Table 48. Merck Description and Business Overview
Table 49. Merck Broad Spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. Merck Broad Spectrum Antibiotics Product
Table 51. Merck Recent Development
Table 52. AbbVie Company Information
Table 53. AbbVie Description and Business Overview
Table 54. AbbVie Broad Spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. AbbVie Broad Spectrum Antibiotics Product
Table 56. AbbVie Recent Development
Table 57. GSK Company Information
Table 58. GSK Description and Business Overview
Table 59. GSK Broad Spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. GSK Broad Spectrum Antibiotics Product
Table 61. GSK Recent Development
Table 62. Pfizer Inc. Company Information
Table 63. Pfizer Inc. Description and Business Overview
Table 64. Pfizer Inc. Broad Spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. Pfizer Inc. Broad Spectrum Antibiotics Product
Table 66. Pfizer Inc. Recent Development
Table 67. Melinta Therapeutics Company Information
Table 68. Melinta Therapeutics Description and Business Overview
Table 69. Melinta Therapeutics Broad Spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. Melinta Therapeutics Broad Spectrum Antibiotics Product
Table 71. Melinta Therapeutics Recent Development
Table 72. Basilea Pharmaceutica Company Information
Table 73. Basilea Pharmaceutica Description and Business Overview
Table 74. Basilea Pharmaceutica Broad Spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. Basilea Pharmaceutica Broad Spectrum Antibiotics Product
Table 76. Basilea Pharmaceutica Recent Development
Table 77. Abbott Company Information
Table 78. Abbott Description and Business Overview
Table 79. Abbott Broad Spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. Abbott Broad Spectrum Antibiotics Product
Table 81. Abbott Recent Development
Table 82. Sanofi Company Information
Table 83. Sanofi Description and Business Overview
Table 84. Sanofi Broad Spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Sanofi Broad Spectrum Antibiotics Product
Table 86. Sanofi Recent Development
Table 87. Novartis AG Company Information
Table 88. Novartis AG Description and Business Overview
Table 89. Novartis AG Broad Spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Novartis AG Broad Spectrum Antibiotics Product
Table 91. Novartis AG Recent Development
Table 92. Bayer AG Company Information
Table 93. Bayer AG Description and Business Overview
Table 94. Bayer AG Broad Spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Bayer AG Broad Spectrum Antibiotics Product
Table 96. Bayer AG Recent Development
Table 97. Bristol Myers Squibb Company Information
Table 98. Bristol Myers Squibb Description and Business Overview
Table 99. Bristol Myers Squibb Broad Spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. Bristol Myers Squibb Broad Spectrum Antibiotics Product
Table 101. Bristol Myers Squibb Recent Development
Table 102. Tetraphase Pharmaceuticals Company Information
Table 103. Tetraphase Pharmaceuticals Description and Business Overview
Table 104. Tetraphase Pharmaceuticals Broad Spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. Tetraphase Pharmaceuticals Broad Spectrum Antibiotics Product
Table 106. Tetraphase Pharmaceuticals Recent Development
Table 107. Paratek Pharmaceuticals Company Information
Table 108. Paratek Pharmaceuticals Description and Business Overview
Table 109. Paratek Pharmaceuticals Broad Spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Paratek Pharmaceuticals Broad Spectrum Antibiotics Product
Table 111. Paratek Pharmaceuticals Recent Development
Table 112. Nabriva Therapeutics Company Information
Table 113. Nabriva Therapeutics Description and Business Overview
Table 114. Nabriva Therapeutics Broad Spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Nabriva Therapeutics Broad Spectrum Antibiotics Product
Table 116. Nabriva Therapeutics Recent Development
Table 117. Spero Therapeutics Company Information
Table 118. Spero Therapeutics Description and Business Overview
Table 119. Spero Therapeutics Broad Spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Spero Therapeutics Broad Spectrum Antibiotics Product
Table 121. Spero Therapeutics Recent Development
Table 122. Janssen Pharmaceuticals Company Information
Table 123. Janssen Pharmaceuticals Description and Business Overview
Table 124. Janssen Pharmaceuticals Broad Spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Janssen Pharmaceuticals Broad Spectrum Antibiotics Product
Table 126. Janssen Pharmaceuticals Recent Development
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Broad Spectrum Antibiotics Customers List
Table 130. Broad Spectrum Antibiotics Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Broad Spectrum Antibiotics Product Picture
Figure 2. Global Broad Spectrum Antibiotics Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Broad Spectrum Antibiotics Market Size 2018-2034 (US$ Million)
Figure 4. Global Broad Spectrum Antibiotics Sales 2018-2034 (K Units)
Figure 5. United States Broad Spectrum Antibiotics Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. United States Broad Spectrum Antibiotics Market Size 2018-2034 (US$ Million)
Figure 7. United States Broad Spectrum Antibiotics Sales 2018-2034 (K Units)
Figure 8. United States Broad Spectrum Antibiotics Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. United States Broad Spectrum Antibiotics Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. Broad Spectrum Antibiotics Report Years Considered
Figure 11. Product Picture of Polypeptide
Figure 12. Product Picture of Aminoglycosides
Figure 13. Product Picture of Tetracycline
Figure 14. Product Picture of Macrolides
Figure 15. Product Picture of Others
Figure 16. Global Broad Spectrum Antibiotics Market Share by Type in 2024 & 2034
Figure 17. Global Broad Spectrum Antibiotics Sales in Value by Type (2018-2034) & (US$ Million)
Figure 18. Global Broad Spectrum Antibiotics Sales Market Share in Value by Type (2018-2034)
Figure 19. Global Broad Spectrum Antibiotics Sales by Type (2018-2034) & (K Units)
Figure 20. Global Broad Spectrum Antibiotics Sales Market Share in Volume by Type (2018-2034)
Figure 21. Global Broad Spectrum Antibiotics Price by Type (2018-2034) & (US$/Unit)
Figure 22. United States Broad Spectrum Antibiotics Market Share by Type in 2024 & 2034
Figure 23. United States Broad Spectrum Antibiotics Sales in Value by Type (2018-2034) & (US$ Million)
Figure 24. United States Broad Spectrum Antibiotics Sales Market Share in Value by Type (2018-2034)
Figure 25. United States Broad Spectrum Antibiotics Sales by Type (2018-2034) & (K Units)
Figure 26. United States Broad Spectrum Antibiotics Sales Market Share in Volume by Type (2018-2034)
Figure 27. United States Broad Spectrum Antibiotics Price by Type (2018-2034) & (US$/Unit)
Figure 28. Product Picture of Hospital Pharmacy
Figure 29. Product Picture of Retail Pharmacy
Figure 30. Product Picture of Online Pharmacy
Figure 31. Global Broad Spectrum Antibiotics Market Share by Application in 2024 & 2034
Figure 32. Global Broad Spectrum Antibiotics Sales in Value by Application (2018-2034) & (US$ Million)
Figure 33. Global Broad Spectrum Antibiotics Sales Market Share in Value by Application (2018-2034)
Figure 34. Global Broad Spectrum Antibiotics Sales by Application (2018-2034) & (K Units)
Figure 35. Global Broad Spectrum Antibiotics Sales Market Share in Volume by Application (2018-2034)
Figure 36. Global Broad Spectrum Antibiotics Price by Application (2018-2034) & (US$/Unit)
Figure 37. United States Broad Spectrum Antibiotics Market Share by Application in 2024 & 2034
Figure 38. United States Broad Spectrum Antibiotics Sales in Value by Application (2018-2034) & (US$ Million)
Figure 39. United States Broad Spectrum Antibiotics Sales Market Share in Value by Application (2018-2034)
Figure 40. United States Broad Spectrum Antibiotics Sales by Application (2018-2034) & (K Units)
Figure 41. United States Broad Spectrum Antibiotics Sales Market Share in Volume by Application (2018-2034)
Figure 42. United States Broad Spectrum Antibiotics Price by Application (2018-2034) & (US$/Unit)
Figure 43. Americas Broad Spectrum Antibiotics Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 44. Americas Broad Spectrum Antibiotics Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 45. Americas Broad Spectrum Antibiotics Sales by Type (2018-2034) & (K Units)
Figure 46. Americas Broad Spectrum Antibiotics Sales Market Share in Volume by Type (2018-2034)
Figure 47. Americas Broad Spectrum Antibiotics Sales by Application (2018-2034) & (K Units)
Figure 48. Americas Broad Spectrum Antibiotics Sales Market Share in Volume by Application (2018-2034)
Figure 49. United States Broad Spectrum Antibiotics Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 50. Canada Broad Spectrum Antibiotics Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 51. Mexico Broad Spectrum Antibiotics Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 52. Brazil Broad Spectrum Antibiotics Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 53. EMEA Broad Spectrum Antibiotics Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 54. EMEA Broad Spectrum Antibiotics Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 55. EMEA Broad Spectrum Antibiotics Sales by Type (2018-2034) & (K Units)
Figure 56. EMEA Broad Spectrum Antibiotics Sales Market Share in Volume by Type (2018-2034)
Figure 57. EMEA Broad Spectrum Antibiotics Sales by Application (2018-2034) & (K Units)
Figure 58. EMEA Broad Spectrum Antibiotics Sales Market Share in Volume by Application (2018-2034)
Figure 59. Europe Broad Spectrum Antibiotics Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 60. Middle East Broad Spectrum Antibiotics Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 61. Africa Broad Spectrum Antibiotics Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 62. China Broad Spectrum Antibiotics Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 63. China Broad Spectrum Antibiotics Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 64. China Broad Spectrum Antibiotics Sales by Type (2018-2034) & (K Units)
Figure 65. China Broad Spectrum Antibiotics Sales Market Share in Volume by Type (2018-2034)
Figure 66. China Broad Spectrum Antibiotics Sales by Application (2018-2034) & (K Units)
Figure 67. China Broad Spectrum Antibiotics Sales Market Share in Volume by Application (2018-2034)
Figure 68. APAC Broad Spectrum Antibiotics Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 69. APAC Broad Spectrum Antibiotics Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 70. APAC Broad Spectrum Antibiotics Sales by Type (2018-2034) & (K Units)
Figure 71. APAC Broad Spectrum Antibiotics Sales Market Share in Volume by Type (2018-2034)
Figure 72. APAC Broad Spectrum Antibiotics Sales by Application (2018-2034) & (K Units)
Figure 73. APAC Broad Spectrum Antibiotics Sales Market Share in Volume by Application (2018-2034)
Figure 74. Japan Broad Spectrum Antibiotics Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 75. South Korea Broad Spectrum Antibiotics Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 76. China Taiwan Broad Spectrum Antibiotics Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 77. Southeast Asia Broad Spectrum Antibiotics Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 78. India Broad Spectrum Antibiotics Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 79. Broad Spectrum Antibiotics Value Chain
Figure 80. Broad Spectrum Antibiotics Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries